Perspective Therapeutics, Inc. (CATX) Tops Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts CATX Hot Sheet
Join SI Premium – FREE
Perspective Therapeutics, Inc. (NYSE: CATX) reported Q1 EPS of ($0.25), $0.06 better than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Perspective Therapeutics, Inc. (CATX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
- Solowin Holdings marks 10 years, expands into stablecoins and AI
- Boeing workers reject contract, authorize strike
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
